Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
|
|
Abraxis BioScience, Inc. (ABII)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/25/2010 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 10/20/2010 |
EFFECT
| Form EFFECT - |
| 10/19/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/19/2010 |
4
| Michele B. Soon-Shiong 2009 Grantor Retained Annuity Trust 1 UAD 9/24/2009 (10% Owner) has filed a Form 4 on Abraxis BioScience, Inc. |
| 10/19/2010 |
4
| CHEN DAVID (Director) has filed a Form 4 on Abraxis BioScience, Inc.|
Txns:
| Disposed/sold 10,000 options to buy
@ $38.08, valued at
$380.8k
Disposed/sold 1,909 options to buy
@ $29.44, valued at
$56.2k
Disposed/sold 1,909 options to buy
@ $34.65, valued at
$66.1k
Disposed/sold 1,272 options to buy
@ $82.94, valued at
$105.5k
Disposed/sold 1,272 options to buy
@ $95.26, valued at
$121.2k
Disposed/sold 2,970 options to buy
@ $94.84, valued at
$281.7k
Disposed/sold 4,243 options to buy
@ $47.3, valued at
$200.7k
Disposed/sold 10,000 options to buy
@ $55.44, valued at
$554.4k
|
|
| 10/19/2010 |
4
| NIMER STEPHEN (Director) has filed a Form 4 on Abraxis BioScience, Inc.|
Txns:
| Disposed/sold 1,875 shares
@ $0
Disposed/sold 10,000 options to buy
@ $38.08, valued at
$380.8k
Disposed/sold 4,773 options to buy
@ $6.29, valued at
$30k
Disposed/sold 4,773 options to buy
@ $25.15, valued at
$120k
Disposed/sold 1,909 options to buy
@ $29.44, valued at
$56.2k
Disposed/sold 1,909 options to buy
@ $34.65, valued at
$66.1k
Disposed/sold 1,272 options to buy
@ $82.94, valued at
$105.5k
Disposed/sold 1,272 options to buy
@ $95.26, valued at
$121.2k
Disposed/sold 2,970 options to buy
@ $94.84, valued at
$281.7k
Disposed/sold 4,243 options to buy
@ $47.3, valued at
$200.7k
Disposed/sold 10,000 options to buy
@ $55.44, valued at
$554.4k
|
|
| 10/19/2010 |
4
| Patrick Soon-Shiong 2009 Grantor Annuity Trust 2 UAD 9/24/2009 (10% Owner) has filed a Form 4 on Abraxis BioScience, Inc. |
| 10/19/2010 |
4
| Patrick Soon-Shiong 2009 Grantor Retained Annuity Trust 1 UAD 9/24/2009 (10% Owner) has filed a Form 4 on Abraxis BioScience, Inc. |
| 10/19/2010 |
4
| SHAPIRO LEONARD (Director) has filed a Form 4 on Abraxis BioScience, Inc.|
Txns:
| Disposed/sold 6,125 shares
@ $0
Disposed/sold 10,000 options to buy
@ $38.08, valued at
$380.8k
Disposed/sold 4,773 options to buy
@ $14.12, valued at
$67.4k
Disposed/sold 1,909 options to buy
@ $34.65, valued at
$66.1k
Disposed/sold 1,272 options to buy
@ $82.94, valued at
$105.5k
Disposed/sold 1,272 options to buy
@ $95.26, valued at
$121.2k
Disposed/sold 2,970 options to buy
@ $94.84, valued at
$281.7k
Disposed/sold 4,243 options to buy
@ $47.3, valued at
$200.7k
Disposed/sold 10,000 options to buy
@ $55.44, valued at
$554.4k
|
|
| 10/19/2010 |
4
| SITRICK MICHAEL S (Director) has filed a Form 4 on Abraxis BioScience, Inc.|
Txns:
| Disposed/sold 10,000 options to buy
@ $38.08, valued at
$380.8k
|
|
| 10/19/2010 |
4
| SOON SHIONG PATRICK (Executive Chairman) has filed a Form 4 on Abraxis BioScience, Inc. |
| 10/19/2010 |
4
| Michele B. Soon-Shiong 2009 Grantor Retained Annuity Trust 2 UAD 9/24/2009 (10% Owner) has filed a Form 4 on Abraxis BioScience, Inc. |
| 10/19/2010 |
4
| Wendel Bruce (CEO) has filed a Form 4 on Abraxis BioScience, Inc. |
| 10/19/2010 |
4
| FOGELMAN MITCHELL K (CFO) has filed a Form 4 on Abraxis BioScience, Inc. |
| 10/18/2010 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/18/2010 |
4
| CELGENE CORP /DE/ (10% Owner) has filed a Form 4 on Abraxis BioScience, Inc. |
| 10/15/2010 |
SC 13D/A
| SOON SHIONG PATRICK reports a 0% stake in ABRAXIS BIOSCIENCE, INC. |
| 10/15/2010 |
8-K
| Quarterly results |
| 10/15/2010 |
25-NSE
| Form 25-NSE - |
| 10/12/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 10/05/2010 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 10/04/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 09/14/2010 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 09/10/2010 |
PRER14A
| Form PRER14A - Preliminary Proxy Soliciting materials |
| 08/05/2010 |
10-Q
| Quarterly Report for the period ended June 30, 2010 |
| 08/04/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 07/30/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 07/30/2010 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 07/29/2010 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition |
| 07/29/2010 |
BW
| Abraxis BioScience and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand |
| 07/23/2010 |
BW
| ABRAXANE® Approved for Marketing in Japan for Breast Cancer |
| 07/19/2010 |
BW
| Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Abraxis BioScience Inc. |
| 07/12/2010 |
BW
| Faruqi & Faruqi, LLP Investigates Potential Breaches of Fiduciary Duties by the Board of Abraxis BioSciences, Inc. - ABII |
| 07/09/2010 |
3
| CELGENE CORP /DE/ (10% Owner) has filed a Form 3 on Abraxis BioScience, Inc. |
|
|
|